It seems like they completely ignored hydroxychloroquine, ivermectin, and the other therapeutics, fluvoxamine, and others, developed no protocol that I know of, yet have now gotten $67 million dollars. This new drug, which they say is a variation on an existing drug that can block the virus looks interesting if it works and they claim is nontoxic two nonthreatened cells--I'll bet they can patent this variation. But if it needs the normal regulatory process it could take years to come to market. Unless it gets emergency use authorization, in which case they throw out all that.
It seems like they completely ignored hydroxychloroquine, ivermectin, and the other therapeutics, fluvoxamine, and others, developed no protocol that I know of, yet have now gotten $67 million dollars. This new drug, which they say is a variation on an existing drug that can block the virus looks interesting if it works and they claim is nontoxic two nonthreatened cells--I'll bet they can patent this variation. But if it needs the normal regulatory process it could take years to come to market. Unless it gets emergency use authorization, in which case they throw out all that.